SCHEMBL21676523

SCHEMBL21676523

Cn1cc2cncnc2n1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.34
ADORA2A P29274 2/20 0.34
EGFR P00533 8/20 0.33
BRAF P15056 1/20 0.33
KDM4E B2RXH2 1/20 0.32
NSD2 O96028 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
MET P08581 1/20 0.31
MAP4K4 O95819 1/20 0.30
FRK P42685 1/20 0.30
MAPK9 P45984 1/20 0.30
CSNK1A1 P48729 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1128922 0.77 EGFR (0.34) EGFR
SCHEMBL309958 0.75 EGFR (0.33) EGFR
SCHEMBL10441379 0.75 EGFR (0.33) EGFR
SCHEMBL5705720 0.75 EGFR (0.33) EGFR
SCHEMBL19421513 0.75 ADORA2A (0.39) ADORA1ADORA2AEGFRADORA3
SCHEMBL21178956 0.75 EGFR (0.31) EGFR
SCHEMBL31507016 0.71 EGFR (0.31) EGFR
SCHEMBL31260572 0.71 EGFR (0.31) EGFR
SCHEMBL22001038 0.69 ADORA2A (0.41) ADORA1ADORA2ABRAFKDM4ENSD2
SCHEMBL6880320 0.69 EGFR (0.37) EGFRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021121282-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS WITH IMMUNOMODULATORY FUNCTION 上海轶诺药业有限公司 2021-06-24 WO disclosed
EP-3772513-A1 SHP2 INHIBITORS C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening (IT) 2021-02-10 EP disclosed
WO-2020024997-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION 上海轶诺药业有限公司 2020-02-06 WO disclosed